Viewing Study NCT00029172



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00029172
Status: COMPLETED
Last Update Posted: 2023-02-16
First Post: 2002-01-08

Brief Title: Treatment for Post-Stroke Depression
Sponsor: Indiana University
Organization: Indiana University

Study Overview

Official Title: Treatment for Post-Stroke Depression
Status: COMPLETED
Status Verified Date: 2009-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate a program of education medicine and monitoring for the treatment of depression after a stroke
Detailed Description: This trial will compare outcomes in depressed patients receiving the Activate-Initiate-Monitor AIM intervention vs those receiving usual care and will also compare outcomes in depressed and non-depressed stroke survivors Patients are screened for depression 1 to 2 months post-stroke Patients with depression are then randomized to the AIM intervention or control group Patients without depression are also enrolled at the same time and are matched by hospital site to the depressed patients

The AIM intervention is a 3-part program consisting of activating or educating the patient and hisher family about post-stroke depression instituting treatment for depression and monitoring antidepressant treatments for side effects efficacy and compliance Control patients are evaluated and treated with usual care by their physicians Patients without depression do not receive the intervention but complete the same assessments on the same schedule as the patients with depression

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None